Dale E. Sharp

1.1k citations
13 papers · 918 · 1 hit paper · h-index 12

Impact in

Papers in

Dale E. Sharp

13 papers receiving 881 citations

Dale E. Sharp's Hit Papers

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors 2011 · 510 citations
5100+5+10Years since publication100200300400500

Peers

Dale E. Sharp
Comparison fields: 5 of 77
  • Endocrinology, Diabetes and Metabolism 463
  • Neurology 94
  • Surgery 218
  • Nephrology 31
  • Analytical Chemistry 45
Replace Ziro Suzuoki with:
Ziro Suzuoki Japan
Kazuharu Ienaga Japan
Joelle M. Onorato United States
Sébastien Bolze France
Nianning Qi United States
Yusuke Moritoh Japan
Ryan A. Frieler United States
Christopher Ho United States
Sam Rebello United States
Miles A. Tanner United States
Dale E. Sharp relative to Ziro Suzuoki Japan Ziro Suzuoki's profile →
Citations per field
00.5×7.5×
Ziro Suzuoki · 1×
Citations per year

Countries citing papers authored by Dale E. Sharp

Since Specialization
Citations

This map shows the geographic impact of Dale E. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale E. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale E. Sharp more than expected).

Fields of papers citing papers by Dale E. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale E. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale E. Sharp. The network helps show where Dale E. Sharp may publish in the future.

Co-authors

The 25 scholars most cited alongside Dale E. Sharp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dale E. Sharp Line = papers co-authored together Dale E. Sharp links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1
Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors
Hit paper breakdown →
2011510
2 1988119
3 198446
4 199839
5 199635
6 198629
7 201429
8 198726
9 201425
10 199022
11 198019
12 198018
13 19801

About Dale E. Sharp

Dale E. Sharp is a scholar working on Organic Chemistry, Endocrinology, Diabetes and Metabolism, Spectroscopy, Plant Science and Molecular Biology, having authored 13 papers that have together received 918 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Analytical Chemistry and Chromatography (3 papers), Plant chemical constituents analysis (2 papers), Synthesis and Reactivity of Sulfur-Containing Compounds (2 papers), Traditional Chinese Medicine Analysis (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Blood properties and coagulation (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (463 citations), Neurology (94 citations), Surgery (218 citations), Nephrology (31 citations) and Analytical Chemistry (45 citations). Dale E. Sharp has collaborated with scholars based in United States and Germany. Frequent co-authors include Peter Eickelmann, Matthias Eckhardt, Remko A. Bakker, Rolf Grempler, Leo Thomas, Michael Mark, Thomas Klein, Achim Sauer, Frank Himmelsbach and Zvani L. Rossetti. Their work appears in journals such as Transfusion, Drug Metabolism and Disposition, The Journal of Organic Chemistry, Xenobiotica and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact